330 results
8-K
EX-99.1
HBIO
Harvard Bioscience Inc.
7 Mar 24
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
7:00am
. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and year ended December 31, 2023.
Jim Green, Chairman and CEO … .”
Green continued, “We remain focused on solidifying our base business and expanding recurring revenue by introducing new products, services
8-K
EX-99.1
id78p0s
5 Jan 24
Results of Operations and Financial Condition
5:01pm
8-K
EX-99.1
4t2frz30dk9cu4dkp2fe
7 Nov 23
Harvard Bioscience Announces Third Quarter 2023 Financial Results
7:00am
UPLOAD
wahl6opyqjpv
16 Aug 23
Letter from SEC
12:00am
8-K
EX-99.1
mpug1 y7ee
8 Aug 23
Harvard Bioscience Announces Second Quarter 2023 Financial Results
9:05am
UPLOAD
8xb cch4qcxhf86
28 Jul 23
Letter from SEC
12:00am
8-K
EX-99.1
qlbfz5 3zxw8nox
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am
8-K
EX-10.1
03kt03 gff
20 Jun 23
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
8:15am